Source:http://linkedlifedata.com/resource/pubmed/id/12887410
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-7-30
|
pubmed:abstractText |
The highly potent micro -opioid receptor agonist 14-methoxymetopon (4,5alpha-epoxy-3-hydroxy-14beta-methoxy-5beta,17-dimethylmorphinan-6-one) was prepared in tritium labelled form by a catalytic dehalogenation method resulting in a specific radioactivity of 15.9 Ci/mmol. Opioid binding characteristics of [3H]14-methoxymetopon were determined using radioligand binding assay in rat brain membranes. [3H]14-Methoxymetopon specifically labelled a single class of opioid sites with affinity in low subnanomolar range (Ki = 0.43 nm) and maximal number of binding sites of 314 fmol/mg protein. Binding of [3H]14-methoxymetopon was inhibited by ligands selective for the micro -opioid receptor with high potency, while selective kappa-opioids and delta-opioids were weaker inhibitors. 14-Methoxymetopon increased guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]GTPgammaS) binding with an EC50 of 70.9 nm, thus, providing evidence for the agonist character of this ligand. The increase of [35S]GTPgammaS binding was inhibited by naloxone and selective micro -opioid antagonists, indicating a micro -opioid receptor-mediated action. [3H]14-Methoxymetopon is one of the few nonpeptide mu-opioid receptor agonists available in radiolabelled form up to now. Due to its high affinity and selectivity, high stability and extremely low nonspecific binding (<10%), this radioligand would be an important and useful tool in probing mu-opioid receptor mechanisms, as well as to promote a further understanding of the opioid system at the cellular and molecular level.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/14-methoxymetopon,
http://linkedlifedata.com/resource/pubmed/chemical/Guanosine 5'-O-(3-Thiotriphosphate),
http://linkedlifedata.com/resource/pubmed/chemical/Morphine Derivatives,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu,
http://linkedlifedata.com/resource/pubmed/chemical/Tritium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0953-816X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12887410-Animals,
pubmed-meshheading:12887410-Binding, Competitive,
pubmed-meshheading:12887410-Brain,
pubmed-meshheading:12887410-Cell Membrane,
pubmed-meshheading:12887410-Guanosine 5'-O-(3-Thiotriphosphate),
pubmed-meshheading:12887410-Morphine Derivatives,
pubmed-meshheading:12887410-Protein Binding,
pubmed-meshheading:12887410-Radioligand Assay,
pubmed-meshheading:12887410-Radiopharmaceuticals,
pubmed-meshheading:12887410-Rats,
pubmed-meshheading:12887410-Rats, Sprague-Dawley,
pubmed-meshheading:12887410-Receptors, Opioid, mu,
pubmed-meshheading:12887410-Signal Transduction,
pubmed-meshheading:12887410-Tritium
|
pubmed:year |
2003
|
pubmed:articleTitle |
Binding characteristics of [3H]14-methoxymetopon, a high affinity mu-opioid receptor agonist.
|
pubmed:affiliation |
Division of Pharmaceutical Chemistry, Department of Pharmacy, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria. Mariana.Spetea@uibk.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|